MLchartDataset catalogue

autologous CD19 CAR-expressing T cells YTB323

Term · Oncology and biomedicine · MLC-T-ONC-011537

A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous CD19 CAR-expressing T cells YTB323 are directed to and induce selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies.

Table 1. Record
IdentifierMLC-T-ONC-011537
FieldOncology and biomedicine
SynonymsCD19-specific CAR T cells YTB323
ReferencesNational Cancer Institute Thesaurus (CC BY 4.0)
Record as JSON
{
  "id": "MLC-T-ONC-011537",
  "term": "autologous CD19 CAR-expressing T cells YTB323",
  "field": "Oncology and biomedicine",
  "definition": "A preparation of autologous T lymphocytes that are genetically engineered to express a chimeric antigen receptor (CAR) specific for the tumor-associated antigen (TAA) CD19, with potential immunostimulating and antineoplastic activities. Upon intravenous administration, the autologous CD19 CAR-expressing T cells YTB323 are directed to and induce selective toxicity in CD19-expressing tumor cells. CD19 antigen is a B-cell specific cell surface antigen expressed in all B-cell lineage malignancies.",
  "synonyms": [
    "CD19-specific CAR T cells YTB323"
  ],
  "references": [
    "National Cancer Institute Thesaurus"
  ],
  "url": "https://mlchart.com/terminology/oncology/autologous-cd19-car-expressing-t-cells-ytb323/"
}

Record 2,871 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.